Concepedia

Author

Katie M. Mishall

University of Colorado Denver

Also Known As

Katie M Mishall, Katie M. Mishall, Katie Mishall

38

Publications

338

Citations

6

H-Index

21

Concepts

All Affiliations

University of Colorado DenverMoffitt Cancer CenterUniversity of South FloridaUniversity of Colorado Cancer Center
KM

About

Katie M. Mishall is an author at University of Colorado Denver specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

248

2

Cell Biology

3

3

232

3

Natural Sciences

1

1

16

4

Biochemistry

1

1

16

5

Chemical Biology

1

1

16

Katie M. Mishall

×

6

Publications

338

Citations

6

H-Index

YearCitations

Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells

Wade M. Borcherds, François‐Xavier Theillet, Andrea Katzer,

Nature Chemical Biology

2014

189

Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling

Sarah K. Nelson-Taylor, Anh T. Le, Minjae Yoo,

Molecular Cancer Therapeutics

2017

78

The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer

Thomas C. Beadnell, Katie M. Mishall, Qiong Zhou,

Molecular Cancer Therapeutics

2016

23

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Brittelle E. Kessler, Katie M. Mishall, M. Kellett,

Oncogene

2018

20

Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides

Bin Fang, Melissa Hoffman, Abu‐Sayeef Mirza,

Methods

2015

16

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer

Katie M. Mishall, Thomas C. Beadnell, Brent M. Kuenzi,

Oncotarget

2017

12

Page 1